Adjunctive 0.8% Hyaluronic Acid Gel in Open-Flap Surgery for Thin Gingival Phenotype in Patients With Periodontitis
Evaluation of the Clinical and Volumetric Effectiveness of 0.8% Hyaluronic Acid Gel Adjunct to Open-Flap Surgery in Periodontitis Patients With Thin Gingival Phenotype
2 other identifiers
interventional
37
1 country
1
Brief Summary
The aim of this study is to evaluate the clinical effectiveness of 0.8% hyaluronic acid (HA) gel as an adjunct to open flap debridement (OFD) in periodontitis patients with a thin gingival phenotype. The primary research question is: Does the adjunctive use of 0.8% HA gel reduce gingival recession and improve clinical parameters? To answer this, researchers will compare the adjunctive use of 0.8% HA gel to physiological saline in combination with OFD, assessing their effects on clinical outcomes and gingival recession in patients with a thin gingival phenotype. Participants will:
- Receive 0.8% HA gel application during OFD surgery and a second application at 4 weeks postoperatively.
- Attend follow-up visits at 1, 3, and 6 months after surgery for clinical assessments and measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 22, 2023
CompletedFirst Submitted
Initial submission to the registry
August 12, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedAugust 27, 2025
August 1, 2025
1.1 years
August 12, 2025
August 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical attachment level (CAL)
CAL were measured from both the buccal and palatal/lingual aspects of each tooth at six points including mesial, distal, and midpoint, and recorded in mm. CAL was measured as the distance between the base of the pocket and the enamel cement junction.
Baseline - 3months - 6 months
Secondary Outcomes (6)
3D Measurements
Baseline - 3months - 6 months
Analysis of 2D Gingival Thickness Changes
Baseline - 3months - 6 months
Relative gingival recession (rGR)
Baseline - 3months - 6 months
Probing depth (PD)
Baseline - 3months - 6 months
Plaque (P)
Baseline - 3months - 6 months
- +1 more secondary outcomes
Study Arms (2)
Open Flap Debridement (OFD)
PLACEBO COMPARATOROpen flap debridement was carried out, and the surgical site was irrigated with physiological saline in a manner consistent with the HA gel application protocol in the test group. A second application of physiological saline to the sulcus area was performed four weeks postoperatively
Open Flap Debridement (OFD)+HA
ACTIVE COMPARATOROpen flap debridement was carried out, and 1 ml of 0.8% HA gel was applied to the root surfaces of the affected teeth, bone, and the inner surface of the flap in the surgical area for 2 minutes. HA gel application was repeated at four weeks postoperatively.
Interventions
After root surface cleaning and infected cement removal, 0.8% HA gel was applied to the root surface, bone, and inner surface of the flap and left for 2 minutes.
In the control group, instead of HA gel, the area was irrigated with physiological saline solution.
Eligibility Criteria
You may qualify if:
- Diagnosis of periodontitis (Stage II/III);
- Presence of horizontal bone loss with at least three adjacent teeth, each exhibiting a probing depth ≥ 5mm and a keratinized tissue width ≥ 2mm on single-rooted teeth;
- a thin gingival phenotype;
- Areas with horizontal bone loss without intra-bony defects, where no additional hard and soft tissue augmentation was required
- a full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS \<20%.
You may not qualify if:
- Systemic diseases
- Smokers
- Pregnant or lactating women
- Those who received periodontal treatment within the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bezmialem Vakif University
Istanbul, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sadiye Gunpinar, Assoc. Prof.
Bezmialem Vakif University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2025
First Posted
August 19, 2025
Study Start
May 9, 2022
Primary Completion
June 22, 2023
Study Completion
June 22, 2023
Last Updated
August 27, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Following the article publication of study protocol in a journal.
- Access Criteria
- The required data can be shared by responsible person (principal investigator of the study) upon reasonable request.
Study protocol and statistical analysis plan.